Recent news on Thyrogen

Genzyme Reports Significant Revenue and Earnings Growth in First ...  -  Apr 25, 2007
WebWire (press release),Also within the Therapeutics area, sales of Thyrogen® (thyrotropin alfa for injection) grew 15 percent to $26.3 million compared with $23.0 million in the

Genzyme Reports Significant Revenue and Earnings Growth in First ...  -  Apr 25, 2007
MSN MoneyAlso within the Therapeutics area, sales of Thyrogen(R) (thyrotropin alfa for injection) grew 15 percent to $26.3 million compared with $23.0 million in the

Genzyme Gets Upgrade From Matrix  -  Mar 15, 2007
Houston Chronicle,Genzyme products include Renagel for kidney disease, Fabrazyme for Fabry disease and Thyrogen thyroid cancer. It is currently developing Myozyme for the

Genzyme Reports Strong Fourth-Quarter Revenue Growth to Conclude ...  -  Jan 10, 2007
Oxfordshire Bioscience Network (press release),Sales of Thyrogen® (thryotropin alfa for injection) increased 18 percent in the fourth quarter to $25 million, compared with $21 million in the same period

Genzyme inaugurates Middle East office in Dubai  09 Nov 2006
...on hemodialysis, Thymoglobulin, an immunosuppressant for treating and preventing acute rejection in renal transplant patients, and Thyrogen, an adjunct to ... -AME Info (press release), Genzyme Reports Strong Third-Quarter Financial Results  Oct 12, 2006
Sales of Thyrogen® (thyrotropin alfa for injection) rose to $22.4 million in the second quarter, a 21 percent increase from sales of $18.5 million during the ... -Yahoo! News (press release) Delivers Solid Earnings Growth Based on Strong Top-Line ...  Jul 18, 2006
Sales of Thyrogen® (thyrotropin alfa for injection) rose to $23.7 million in the second quarter, a 15 percent increase from sales of $20.7 million during the ... -Oxfordshire Bioscience Network



Genzyme Reports Financial Results for the First Quarter of 2006  Apr 19, 2006
Sales of Thyrogen(R) (thyrotropin alfa for injection) increased 30 percent to $23 million in the first quarter, up from $17.7 million a year earlier. ... - MSN Money

Zacks Bull and Bear of the Day Highlights: Linear Technology ...  Apr 24, 2006
We are optimistic about the strong growth of its key products particularly that of Thyrogen and Synvisc. Launch of Myozyme in 2006 will further support growth. ... - Black Enterprise





Genzyme OK'd to change Thyrogen label  Feb 1, 2006
CAMBRIDGE, Mass., Feb. 1 (UPI) -- Genzyme said it has been cleared to change thyroid-cancer drug Thyrogen's labeling to reflect improved quality of life. ... - United Press International

Genzyme Granted Label Change for Thyrogen  Feb 1, 2006
...(Nasdaq:GENZ) today announced that the US Food and Drug Administration (FDA) has authorized a label modification for Thyrogen® (thyrotropin alfa for injection ... - WebWire,

Mass., Maine, NStar oppose energy agreement  Feb 2, 2006
...said a new analysis of data allows it to change the label for its cancer treatment Thyrogen to include improvement across all categories in a standard quality ... - Boston Globe,

Genzyme Granted Label Change for Thyrogen  Feb 1, 2006
...today announced that the US Food and Drug Administration (FDA) has authorized a label modification for Thyrogen(R) (thyrotropin alfa for injection) to reflect ... - International News Service

Genzyme OK'd to change Thyrogen label  Feb 1, 2006
CAMBRIDGE, Mass., Feb. 1 (UPI) -- Genzyme said it has been cleared to change thyroid-cancer drug Thyrogen's labeling to reflect improved quality of life. ... - United Press International

Genzyme Granted Label Change for Thyrogen  Feb 1, 2006
...(Nasdaq:GENZ) today announced that the US Food and Drug Administration (FDA) has authorized a label modification for Thyrogen® (thyrotropin alfa for injection ... - WebWire

Mass., Maine, NStar oppose energy agreement  Feb 2, 2006
...said a new analysis of data allows it to change the label for its cancer treatment Thyrogen to include improvement across all categories in a standard quality ... - Boston Globe

Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue  Jan 9, 2006
Sales of Thyrogen(R) (thyrotropin alfa for injection) increased 18 percent to $21 million in the fourth quarter from $18 million in the same period a year ... - MSN Money

Genzyme's Revenue Set to Climb  Jan 9, 2006
...increase of 27% to $81 million. Sales of the thyroid drug Thyrogen were up 18% to $21 million. Genzyme issued initial projections of ... - TheStreet.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional